Trials / Unknown
UnknownNCT04384094
Defining the Operating Parameters for a Rebound-esthesiometer
Rebound Esthesiometer Phase 2 Protocol
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Icare Finland Oy · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to define the operating parameters for a new method to measure corneal sensitivity.
Detailed description
Corneal sensitivity is the most important protective mechanism of the eye. Thus, measuring it at any given time gives important indicators of corneal physiology, especially in the diagnostics of corneal and systemic diseases (e.g. diabetes, herpes simplex and keratitis) and recovery from ocular surgery. Current commercial measurement methods are outdated, non-quantitative and uncomfortable to use, hence left unused. This results in suboptimal, even poor, diagnosis and treatment for patients. In this study the operating parameters for a state-of-the-art esthesiometer are defined. The operating principle is based on existing rebound technology which is already approved for IOP measurement.
Conditions
- Corneal Sensation Reduced
- Corneal Dystrophy
- Corneal Degeneration
- Corneal Transplant Failure
- Herpetic Keratitis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Esthesiometer measurement | Measuring the corneal sensitivity using rebound technology. |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2020-05-12
- Last updated
- 2020-07-29
Source: ClinicalTrials.gov record NCT04384094. Inclusion in this directory is not an endorsement.